%0 Journal Article
%T Generalization and representativeness of phase III immune checkpoint blockade trials in nonŠ\small cell lung cancer
%A Bhumsuk Keam
%A Dae Seog Heo
%A DongŠ\Wan Kim
%A Miso Kim
%A Shin Hye Yoo
%A Tae Min Kim
%J Archive of "Thoracic Cancer".
%D 2018
%R 10.1111/1759-7714.12641
%X Strict eligibility criteria for patient enrollment in phase III trials raise questions regarding generalization to ineligible patients. We evaluated whether pivotal phase III trials of immune checkpoint blockades (ICBs) represent the overall population of nonŠ\small cell lung cancer (NSCLC) patients
%K Clinical trial
%K eligibility
%K generalization
%K immune checkpoint blockade
%K nonŠ\small cell lung cancer
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456815/